Company intelligence / Profile preview
Switzer Lifescience
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
Overview
Switzer Lifescience manufactures and markets over 200 pharmaceutical formulations in various dosage forms, focusing on commercial supply of generics and branded formulations across human and veterinary therapeutic segments. The company operates WHO-cGMP certified manufacturing facilities and exports to over 30 countries.
- Therapeutic areas
- CardiovascularImmunologyGastroenterologyPulmonologyNeurologyInfectious DiseasesMetabolic DisordersMen's HealthOtherPsychiatryOncology
- Modalities
- Small moleculeBiologicSoft gelatin capsuleTabletCapsuleOral liquidOintmentInjectionDry syrup
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Switzer Lifescience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Switzer Lifescience.